Cargando…

Comparison of the CES-D and PHQ-9 depression scales in people with type 2 diabetes in Tehran, Iran

BACKGROUND: The quality of life in patients with various chronic disorders, including diabetes has been directly affected by depression. Depression makes patients less likely to manage their self-care regimens. Accurate assessment of depression in diabetic populations is important to the treatment o...

Descripción completa

Detalles Bibliográficos
Autores principales: Khamseh, Mohammad E, Baradaran, Hamid R, Javanbakht, Anna, Mirghorbani, Maryam, Yadollahi, Zahra, Malek, Mojtaba
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3102614/
https://www.ncbi.nlm.nih.gov/pubmed/21496289
http://dx.doi.org/10.1186/1471-244X-11-61
_version_ 1782204393978855424
author Khamseh, Mohammad E
Baradaran, Hamid R
Javanbakht, Anna
Mirghorbani, Maryam
Yadollahi, Zahra
Malek, Mojtaba
author_facet Khamseh, Mohammad E
Baradaran, Hamid R
Javanbakht, Anna
Mirghorbani, Maryam
Yadollahi, Zahra
Malek, Mojtaba
author_sort Khamseh, Mohammad E
collection PubMed
description BACKGROUND: The quality of life in patients with various chronic disorders, including diabetes has been directly affected by depression. Depression makes patients less likely to manage their self-care regimens. Accurate assessment of depression in diabetic populations is important to the treatment of depression in this group and may improve diabetes management. To our best knowledge, there are few studies that have looked for utilizing questionnaires in screening for depression among patients with diabetes in Iran. Therefore the aim of this study was to assess the efficacy and accuracy of the Center for Epidemiological Studies Depression (CES-D) scale and the Patient Health Questionnaire-9 (PHQ-9), in comparison with clinical interview in people with type 2 diabetes. METHODS: Outpatients who attended diabetes clinics at IEM were recruited on a consecutive basis between February 2009 and July 2009. Inclusion criteria included patients with type 2 diabetes who could fluently read and speak Persian, had no severe diabetes complications and no history of psychological disorders. The history of psychological disorders was ascertained through patients' medical files, taking history of any medications in this regard. The study design was explained to all patients and informed consent was obtained. Volunteer patients completed the Persian version of the questionnaires (CES-D and PHQ-9) and a psychiatrist interviewed them based on Structured Clinical Interview (SCID) for DSM-IV criteria. RESULTS: Of the 185 patients, 43.2% were diagnosed as having Major Depressive Disorder (MDD) based on the clinical interview, 47.6% with PHQ-9 and 61.62% with CES-D. The Area Under the Curve (AUC) for the total score of PHQ-9 was 0.829 ± 0.30. A cut-off score for PHQ-9 of ≥ 13 provided an optimal balance between sensitivity (73.80%) and specificity (76.20%). For CES-D the AUC for the total score was 0.861 ± 0.029. Optimal balance between sensitivity (78.80%) and specificity (77.1%) was provided at cut-off score of ≥ 23. CONCLUSIONS: It could be concluded that the PHQ-9 and CES-D perform well as screening instruments, but in diagnosing major depressive disorder, a formal diagnostic process following the PHQ-9 and also the CES-D remains essential.
format Text
id pubmed-3102614
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31026142011-05-27 Comparison of the CES-D and PHQ-9 depression scales in people with type 2 diabetes in Tehran, Iran Khamseh, Mohammad E Baradaran, Hamid R Javanbakht, Anna Mirghorbani, Maryam Yadollahi, Zahra Malek, Mojtaba BMC Psychiatry Research Article BACKGROUND: The quality of life in patients with various chronic disorders, including diabetes has been directly affected by depression. Depression makes patients less likely to manage their self-care regimens. Accurate assessment of depression in diabetic populations is important to the treatment of depression in this group and may improve diabetes management. To our best knowledge, there are few studies that have looked for utilizing questionnaires in screening for depression among patients with diabetes in Iran. Therefore the aim of this study was to assess the efficacy and accuracy of the Center for Epidemiological Studies Depression (CES-D) scale and the Patient Health Questionnaire-9 (PHQ-9), in comparison with clinical interview in people with type 2 diabetes. METHODS: Outpatients who attended diabetes clinics at IEM were recruited on a consecutive basis between February 2009 and July 2009. Inclusion criteria included patients with type 2 diabetes who could fluently read and speak Persian, had no severe diabetes complications and no history of psychological disorders. The history of psychological disorders was ascertained through patients' medical files, taking history of any medications in this regard. The study design was explained to all patients and informed consent was obtained. Volunteer patients completed the Persian version of the questionnaires (CES-D and PHQ-9) and a psychiatrist interviewed them based on Structured Clinical Interview (SCID) for DSM-IV criteria. RESULTS: Of the 185 patients, 43.2% were diagnosed as having Major Depressive Disorder (MDD) based on the clinical interview, 47.6% with PHQ-9 and 61.62% with CES-D. The Area Under the Curve (AUC) for the total score of PHQ-9 was 0.829 ± 0.30. A cut-off score for PHQ-9 of ≥ 13 provided an optimal balance between sensitivity (73.80%) and specificity (76.20%). For CES-D the AUC for the total score was 0.861 ± 0.029. Optimal balance between sensitivity (78.80%) and specificity (77.1%) was provided at cut-off score of ≥ 23. CONCLUSIONS: It could be concluded that the PHQ-9 and CES-D perform well as screening instruments, but in diagnosing major depressive disorder, a formal diagnostic process following the PHQ-9 and also the CES-D remains essential. BioMed Central 2011-04-16 /pmc/articles/PMC3102614/ /pubmed/21496289 http://dx.doi.org/10.1186/1471-244X-11-61 Text en Copyright ©2011 Khamseh et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Khamseh, Mohammad E
Baradaran, Hamid R
Javanbakht, Anna
Mirghorbani, Maryam
Yadollahi, Zahra
Malek, Mojtaba
Comparison of the CES-D and PHQ-9 depression scales in people with type 2 diabetes in Tehran, Iran
title Comparison of the CES-D and PHQ-9 depression scales in people with type 2 diabetes in Tehran, Iran
title_full Comparison of the CES-D and PHQ-9 depression scales in people with type 2 diabetes in Tehran, Iran
title_fullStr Comparison of the CES-D and PHQ-9 depression scales in people with type 2 diabetes in Tehran, Iran
title_full_unstemmed Comparison of the CES-D and PHQ-9 depression scales in people with type 2 diabetes in Tehran, Iran
title_short Comparison of the CES-D and PHQ-9 depression scales in people with type 2 diabetes in Tehran, Iran
title_sort comparison of the ces-d and phq-9 depression scales in people with type 2 diabetes in tehran, iran
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3102614/
https://www.ncbi.nlm.nih.gov/pubmed/21496289
http://dx.doi.org/10.1186/1471-244X-11-61
work_keys_str_mv AT khamsehmohammade comparisonofthecesdandphq9depressionscalesinpeoplewithtype2diabetesintehraniran
AT baradaranhamidr comparisonofthecesdandphq9depressionscalesinpeoplewithtype2diabetesintehraniran
AT javanbakhtanna comparisonofthecesdandphq9depressionscalesinpeoplewithtype2diabetesintehraniran
AT mirghorbanimaryam comparisonofthecesdandphq9depressionscalesinpeoplewithtype2diabetesintehraniran
AT yadollahizahra comparisonofthecesdandphq9depressionscalesinpeoplewithtype2diabetesintehraniran
AT malekmojtaba comparisonofthecesdandphq9depressionscalesinpeoplewithtype2diabetesintehraniran